WHWK(Whitehawk Therapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $14.00M | $15.22M | $24.35M | $25.98M | $7.14M |
| 毛利润 | $14.00M | $13.88M | $21.55M | $22.96M | $6.38M |
| 营业利润 | −$111.22M | −$62.68M | −$71.93M | −$67.46M | −$114.40M |
| 净利润 | −$110.09M | −$60.51M | −$65.77M | −$63.69M | −$20.60M |
| 经营现金流 | −$22.42M | −$49.64M | −$59.66M | −$59.55M | −$97.43M |
| 自由现金流 | −$22.47M | −$50.08M | −$63.63M | −$61.20M | −$97.98M |
| 摊薄每股收益 | $-12.41 | $-2.69 | $-2.44 | $-2.36 | $-0.33 |